Cargando…
Metabolic Plasticity Is an Essential Requirement of Acquired Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia
SIMPLE SUMMARY: Tyrosine kinase inhibitors (TKIs), such as imatinib, have become the standard initial treatment of choice for chronic myeloid leukemia (CML) patients. However, one obstacle to face is that a significant proportion of patients presents poor response to TKIs, or acquires resistance res...
Autores principales: | Mostazo, Miriam G. Contreras, Kurrle, Nina, Casado, Marta, Fuhrmann, Dominik, Alshamleh, Islam, Häupl, Björn, Martín-Sanz, Paloma, Brüne, Bernhard, Serve, Hubert, Schwalbe, Harald, Schnütgen, Frank, Marin, Silvia, Cascante, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699488/ https://www.ncbi.nlm.nih.gov/pubmed/33228196 http://dx.doi.org/10.3390/cancers12113443 |
Ejemplares similares
-
Metabolic Plasticity of Acute Myeloid Leukemia
por: Kreitz, Johanna, et al.
Publicado: (2019) -
Real‐Time NMR Spectroscopy for Studying Metabolism
por: Alshamleh, Islam, et al.
Publicado: (2019) -
Genome-scale integration of transcriptome and metabolome unveils squalene synthase and dihydrofolate reductase as targets against AML cells resistant to chemotherapy
por: Karakitsou, Effrosyni, et al.
Publicado: (2021) -
Identification of the Cysteine Protease Legumain as a Potential Chronic Hypoxia-Specific Multiple Myeloma Target Gene
por: Clees, Ada-Sophia, et al.
Publicado: (2022) -
Synthesis and in Vitro Evaluation of Novel 5‐Nitroindole Derivatives as c‐Myc G‐Quadruplex Binders with Anticancer Activity
por: Nimbarte, Vijaykumar D., et al.
Publicado: (2021)